The scientist’s investigation covers issues in Antibody, Virology, Epitope, Severe acute respiratory syndrome coronavirus 2 and Internal medicine. His work on Neutralization and Monoclonal antibody is typically connected to Antibody Classes as part of general Antibody study, connecting several disciplines of science. His Monoclonal antibody research includes themes of Lipid bilayer fusion, Peptide sequence, Cell biology, Allosteric regulation and Viral protein.
His work carried out in the field of Virology brings together such families of science as Early phase and Age and sex. The study incorporates disciplines such as Vaccine efficacy and Vaccination in addition to Internal medicine. His study with Ebola virus involves better knowledge in Immunology.
His main research concerns Virology, Virus, Antibody, Ebola virus and Severe acute respiratory syndrome coronavirus 2. His Virology research incorporates elements of RNA and Immune system, Immunity. His research integrates issues of Transmission, Genome and Binding site in his study of Virus.
His research investigates the connection with Antibody and areas like Vaccination which intersect with concerns in Ebola vaccine. His Zaire ebolavirus study in the realm of Ebola virus connects with subjects such as Sierra leone. Miles W. Carroll conducts interdisciplinary study in the fields of Epitope and Coronavirus through his works.
His main research concerns Virology, Virus, Antibody, Severe acute respiratory syndrome coronavirus 2 and Immune system. His Virology study integrates concerns from other disciplines, such as RNA and Respiratory tract. His studies deal with areas such as Viral evolution, Sequence analysis and Genetic diversity as well as Virus.
His Antibody study frequently draws connections between adjacent fields such as Vaccination. Miles W. Carroll works mostly in the field of Immune system, limiting it down to concerns involving Ebola virus and, occasionally, Nucleoprotein and Virus classification. His studies in Neutralization integrate themes in fields like Anticoagulant, Receptor, IC50 and Heparin.
Miles W. Carroll mostly deals with Antibody, Virology, Neutralization, Monoclonal antibody and Virus. His work in the fields of Neutralizing antibody and Immunogenicity overlaps with other areas such as Coronavirus. Miles W. Carroll connects Virology with Severe acute respiratory syndrome coronavirus 2 in his research.
His Neutralization study incorporates themes from Vero cell, In vitro and Receptor. His Virus research integrates issues from RNA, Lung, Dose–response relationship and Nasal administration. He has included themes like Transmission, Booster dose and Viral replication in his Vaccination study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Real-time, portable genome sequencing for Ebola surveillance
Joshua Quick;Nicholas J. Loman;Sophie Duraffour;Jared T. Simpson;Jared T. Simpson.
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!).
Ana Maria Henao-Restrepo;Anton Camacho;Ira M. Longini;Conall H. Watson.
The Lancet (2017)
Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial
Ana Maria Henao-Restrepo;Ira M Longini;Matthias Egger;Matthias Egger;Natalie E Dean.
The Lancet (2015)
GP100/PMEL 17 IS A MURINE TUMOR REJECTION ANTIGEN : INDUCTION OF SELF -REACTIVE, TUMORICIDAL T CELLS USING HIGH-AFFINITY, ALTERED PEPTIDE LIGAND
Willem W. Overwijk;Allan Tsung;Kari R. Irvine;Maria R. Parkhurst.
Journal of Experimental Medicine (1998)
Host Range and Cytopathogenicity of the Highly Attenuated MVA Strain of Vaccinia Virus: Propagation and Generation of Recombinant Viruses in a Nonhuman Mammalian Cell Line
Miles W Carroll;Bernard Moss.
Vaccination with a recombinant vaccinia virus encoding a “self” antigen induces autoimmune vitiligo and tumor cell destruction in mice: Requirement for CD4+ T lymphocytes
Willem W. Overwijk;David S. Lee;Deborah R. Surman;Kari R. Irvine.
Proceedings of the National Academy of Sciences of the United States of America (1999)
Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara.
V M Hirsch;T R Fuerst;G Sutter;M W Carroll.
Journal of Virology (1996)
Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples
Joshua Quick;Nathan D Grubaugh;Steven T Pullan;Ingra M Claro.
Nature Protocols (2017)
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera.
D Zhou;W Dejnirattisai;P Supasa;C Liu.
Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.
Daouda Sissoko;Cedric Laouenan;Elin Folkesson;Abdoul-Bing M’Lebing.
PLOS Medicine (2016)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: